The group's principle activity is to provide personal and public access cardiac rhythm management. The group’s products are cardiac defibrillation, pacing and cardioversion, Scope Biphasic waveform technology, diagonistics algorithms, innovative sensor and defibrillator electrode technologies. The group operates from Northern Ireland.
